Oligomerization of opioid receptors: Generation of novel signaling units

Current Opinion in Pharmacology

Volumn 2, Issue 1, 2002, Pages 76-81

  Levac, Brandon A R ^a   O'Dowd, Brian F ^a,b   George, Susan R ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 7 BENZYLIDENENALTREXONE; ADENYLATE CYCLASE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; DIPRENORPHINE; DYNORPHIN A; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; ETORPHINE; G PROTEIN COUPLED RECEPTOR; GTP BINDING PROTEIN REGULATORS; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; MORPHINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONE; NORBINALTORPHIMINE; OLIGOMER; OPIATE DERIVATIVE; OPIATE RECEPTOR; UNINDEXED DRUG;

AMINO ACID SEQUENCE; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMISTRY; COMPLEX FORMATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG RESEARCH; DRUG TARGETING; GENETICS; HUMAN; LIGAND BINDING; MOLECULAR GENETICS; MOUSE; NONHUMAN; OLIGOMERIZATION; PHYSIOLOGY; PROTEIN PROTEIN INTERACTION; RECEPTOR INTRINSIC ACTIVITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; GTP-BINDING PROTEIN REGULATORS; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, OPIOID;

EID: 0036462451     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4892(02)00124-8     Document Type: Review

References (36)

1. Oligmerization of G-protein-coupled transmitter receptors
2. G protein coupled receptor dimerization: Implications in modulating receptor function
3. Oligomerization of μ- and δ-opioid receptors. Generation of novel functional properties
4. G-protein-coupled receptor heterodimerization modulates receptor function
5. Heterodimerization of μ and δ opioid receptors: A role in opiate synergy
6. Antibodies to the cloned μ-opioid receptor detect various molecular weight forms in areas of mouse brain
7. Dimerization of the δ opioid receptor: Implication for a role receptor internalization
8. Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer
9. 2 dopamine receptors exist as oligomers in the cell
10. From models to molecules: Opioid receptor dimers, bivalent ligands, and selective opioid receptor probes
11. Increased biological activity of dimers of oxymorphone and enkephalin: Possible role of receptor crosslinking
12. Dimeric enkephalins display enhanced affinity and selectivity for the delta opiate receptor
13. Dimeric tetrapetide enkephalins display extraordinary selectivity for the δ opiate receptor
14. 3H]bremazocine binding in single and combinatorial opioid receptor knockout mice
15. δ-opioid receptor subtypes and cross-talk with μ-receptors
16. 1 signaling
17. 3 cells
18. Opioids and their complicated receptor complexes
19. Lack of dependence and rewarding effects of deltomorphin II in mu-opioid receptor -deficient mice
20. 5]enkephalin-induced analgesia
21. Activity of the δ-opioid receptor is partially reduced, whereas activity of the κ-receptor is maintained in mice lacking the μ-receptor
22. 35S]GTPγS binding in μ receptor knockout
23. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in γ opioid receptor knockout mice
24. Quantitative autoradiographic mapping of μ-, δ- and κ-opioid receptors in knockout mice lacking the μ-opioid receptor gene
25. Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ-agonist U-50,488H and attenuates morphine withdrawal
26. μ-opposing actions of the κ-opioid receptor
27. 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation
28. Insights into mu opioid pharmacology The role of mu opioid receptor subtypes
29. 3 subtype
30. Opioids: First lesson from knockout mice
31. Molecular mechanisms and regulation of opioid receptor signaling
32. Both μ and δ opiate receptors exist on the same neuron
33. Multiple opiate receptors on neurons of the mammalian central nervous system. In vivo and in vitro studies
34. Dual ultrastructural immunocytochemical labelling of μ and δ opioid receptors in the superficial layers of the rat cervical spinal cord
35. Characterization of opioid receptors modulating neurogenic contradictions of circular muscle from porcine ileum and evidence that δ and κ-opioid receptors are coexpressed in myenteric neurons
36. Prolonged morphine treatment targets δ opioid receptors to neuronal plasma membranes and enhances δ-mediated antinociception